[go: up one dir, main page]

WO1993017651A3 - Analogues nucleosidiques antiviraux, leur fabrication et leur utilisation - Google Patents

Analogues nucleosidiques antiviraux, leur fabrication et leur utilisation Download PDF

Info

Publication number
WO1993017651A3
WO1993017651A3 PCT/DE1993/000213 DE9300213W WO9317651A3 WO 1993017651 A3 WO1993017651 A3 WO 1993017651A3 DE 9300213 W DE9300213 W DE 9300213W WO 9317651 A3 WO9317651 A3 WO 9317651A3
Authority
WO
WIPO (PCT)
Prior art keywords
production
nucleoside analogues
antiviral nucleoside
antiviral
disclosed
Prior art date
Application number
PCT/DE1993/000213
Other languages
German (de)
English (en)
Other versions
WO1993017651A2 (fr
Inventor
Eckart Matthes
Janta-Lipinski Martin Von
Original Assignee
Max Delbrueck Centrum
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Delbrueck Centrum filed Critical Max Delbrueck Centrum
Publication of WO1993017651A2 publication Critical patent/WO1993017651A2/fr
Publication of WO1993017651A3 publication Critical patent/WO1993017651A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne des analogues nucléosidiques connus, ainsi que des nouveaux, qui sont particulièrement actifs dans le traitement contre l'hépatite B et les infections à VIH. L'invention concerne également leur fabrication et leur utilisation.
PCT/DE1993/000213 1992-03-04 1993-03-03 Analogues nucleosidiques antiviraux, leur fabrication et leur utilisation WO1993017651A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEP4207363.4 1992-03-04
DE19924207363 DE4207363A1 (de) 1992-03-04 1992-03-04 Antivirale nucleosidanaloga, ihre herstellung und ihre pharmazeutische verwendung

Publications (2)

Publication Number Publication Date
WO1993017651A2 WO1993017651A2 (fr) 1993-09-16
WO1993017651A3 true WO1993017651A3 (fr) 1993-11-25

Family

ID=6453548

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DE1993/000213 WO1993017651A2 (fr) 1992-03-04 1993-03-03 Analogues nucleosidiques antiviraux, leur fabrication et leur utilisation

Country Status (2)

Country Link
DE (1) DE4207363A1 (fr)
WO (1) WO1993017651A2 (fr)

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9109001B2 (en) 2012-05-22 2015-08-18 Idenix Pharmaceuticals, Inc. 3′,5′-cyclic phosphoramidate prodrugs for HCV infection
US9187515B2 (en) 2013-04-01 2015-11-17 Idenix Pharmaceuticals Llc 2′,4′-fluoro nucleosides for the treatment of HCV
US9192621B2 (en) 2012-09-27 2015-11-24 Idenix Pharmaceuticals Llc Esters and malonates of SATE prodrugs
US9211300B2 (en) 2012-12-19 2015-12-15 Idenix Pharmaceuticals Llc 4′-fluoro nucleosides for the treatment of HCV
US9243025B2 (en) 2011-03-31 2016-01-26 Idenix Pharmaceuticals, Llc Compounds and pharmaceutical compositions for the treatment of viral infections
US9296778B2 (en) 2012-05-22 2016-03-29 Idenix Pharmaceuticals, Inc. 3′,5′-cyclic phosphate prodrugs for HCV infection
US9309275B2 (en) 2013-03-04 2016-04-12 Idenix Pharmaceuticals Llc 3′-deoxy nucleosides for the treatment of HCV
US9403863B2 (en) 2011-09-12 2016-08-02 Idenix Pharmaceuticals Llc Substituted carbonyloxymethylphosphoramidate compounds and pharmaceutical compositions for the treatment of viral infections
US10005779B2 (en) 2013-06-05 2018-06-26 Idenix Pharmaceuticals Llc 1′,4′-thio nucleosides for the treatment of HCV
US10202411B2 (en) 2014-04-16 2019-02-12 Idenix Pharmaceuticals Llc 3′-substituted methyl or alkynyl nucleosides nucleotides for the treatment of HCV
US10231986B2 (en) 2013-03-13 2019-03-19 Idenix Pharmaceuticals Llc Amino acid phosphoramidate pronucleotides of 2′-cyano, azido and amino nucleosides for the treatment of HCV
US10238680B2 (en) 2013-08-01 2019-03-26 Idenix Pharmaceuticals Llc D-amino acid phosphoramidate pronucleotides of halogeno pyrimidine compounds for liver disease
US10513534B2 (en) 2012-10-08 2019-12-24 Idenix Pharmaceuticals Llc 2′-chloro nucleoside analogs for HCV infection
US10717758B2 (en) 2012-05-22 2020-07-21 Idenix Pharmaceuticals Llc D-amino acid compounds for liver disease

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995022330A1 (fr) * 1994-02-17 1995-08-24 Commonwealth Scientific And Industrial Research Organisation Agents antiviraux
EA200601591A1 (ru) 2000-05-26 2007-02-27 Айденикс (Кайман) Лимитед Применение рибонуклеозидных соединений для лечения флавивирусных и пестивирусных инфекций
GB0114286D0 (en) 2001-06-12 2001-08-01 Hoffmann La Roche Nucleoside Derivatives
US7824851B2 (en) 2002-11-15 2010-11-02 Idenix Pharmaceuticals, Inc. 2′-branched nucleosides and Flaviviridae mutation
CN100351264C (zh) * 2002-11-19 2007-11-28 霍夫曼-拉罗奇有限公司 抗病毒核苷衍生物
TWI332507B (en) * 2002-11-19 2010-11-01 Hoffmann La Roche Antiviral nucleoside derivatives
CN101310021A (zh) * 2005-09-26 2008-11-19 法莫赛特股份有限公司 作为抗病毒剂的修饰的4’-核苷
US7951789B2 (en) 2006-12-28 2011-05-31 Idenix Pharmaceuticals, Inc. Compounds and pharmaceutical compositions for the treatment of viral infections
WO2013017853A2 (fr) * 2011-07-29 2013-02-07 Cambridge Epigenetix Limited Procédés de détection d'une modification nucléotidique
MX2014014323A (es) 2012-05-25 2015-02-12 Janssen R & D Ireland Nucleosidos de espirooxetano de uracilo.
WO2014137930A1 (fr) 2013-03-04 2014-09-12 Idenix Pharmaceuticals, Inc. Nucléosides de thiophosphate pour le traitement du vhc
CN104193801A (zh) * 2014-08-12 2014-12-10 苏州维泰生物技术有限公司 一种鸟嘌呤肽核酸单体及其合成方法
GB2589205B (en) * 2018-03-07 2023-05-24 Univ Emory 4'-halogen containing nucleotide and nucleoside therapeutic compositions and uses related thereto

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0277599A2 (fr) * 1987-01-30 1988-08-10 Asahi Glass Company Ltd. Dérivés de cyclopentane contenant du fluor et procédés pour leur préparation
EP0322384A1 (fr) * 1987-11-03 1989-06-28 Medivir Aktiebolag Nucléosides pour utilisation en thérapie
EP0375183A1 (fr) * 1988-12-05 1990-06-27 Schering Corporation Dimers et trimers antiviraux
WO1991019727A1 (fr) * 1990-06-19 1991-12-26 Sloan-Kettering Institute For Cancer Research 5-hydrogenophosphonates et 5'-methylphosphonates de nucleosides modifies du sucre, compositions et utilisations de ces produits pour traiter des infections virales
EP0464642A1 (fr) * 1990-07-02 1992-01-08 Hoechst Aktiengesellschaft Dérivés de pyrimidine, leur production et utilisation et préparations médicinales les contenant
EP0302760B1 (fr) * 1987-08-07 1992-07-29 The Governors of the University of Alberta Thérapie antivirale contre l'hépatite B employant des 2',3'-didéoxynucléosides

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0277599A2 (fr) * 1987-01-30 1988-08-10 Asahi Glass Company Ltd. Dérivés de cyclopentane contenant du fluor et procédés pour leur préparation
EP0302760B1 (fr) * 1987-08-07 1992-07-29 The Governors of the University of Alberta Thérapie antivirale contre l'hépatite B employant des 2',3'-didéoxynucléosides
EP0322384A1 (fr) * 1987-11-03 1989-06-28 Medivir Aktiebolag Nucléosides pour utilisation en thérapie
EP0375183A1 (fr) * 1988-12-05 1990-06-27 Schering Corporation Dimers et trimers antiviraux
WO1991019727A1 (fr) * 1990-06-19 1991-12-26 Sloan-Kettering Institute For Cancer Research 5-hydrogenophosphonates et 5'-methylphosphonates de nucleosides modifies du sucre, compositions et utilisations de ces produits pour traiter des infections virales
EP0464642A1 (fr) * 1990-07-02 1992-01-08 Hoechst Aktiengesellschaft Dérivés de pyrimidine, leur production et utilisation et préparations médicinales les contenant

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
JOURNAL OF ORGANIC CHEMISTRY. Bd. 41, Nr. 18, 3. September 1976, EASTON US Seiten 3010 - 3017 G.R.OWEN ET AL. '4'-Substituted Nucleosides. 3.Synthesis of Some 4'-Fluorouridine Derivatives.' *
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY. Bd. 98, Nr. 11, 26. Mai 1976, GASTON, PA US Seiten 3346 - 3357 I.D.JENKINS ET AL. '4'-Substituted Nucleosides. 2. Synthesis of the Nucleoside Antibiotic Nucleocidin.' *

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9243025B2 (en) 2011-03-31 2016-01-26 Idenix Pharmaceuticals, Llc Compounds and pharmaceutical compositions for the treatment of viral infections
US9403863B2 (en) 2011-09-12 2016-08-02 Idenix Pharmaceuticals Llc Substituted carbonyloxymethylphosphoramidate compounds and pharmaceutical compositions for the treatment of viral infections
US10717758B2 (en) 2012-05-22 2020-07-21 Idenix Pharmaceuticals Llc D-amino acid compounds for liver disease
US9296778B2 (en) 2012-05-22 2016-03-29 Idenix Pharmaceuticals, Inc. 3′,5′-cyclic phosphate prodrugs for HCV infection
US9109001B2 (en) 2012-05-22 2015-08-18 Idenix Pharmaceuticals, Inc. 3′,5′-cyclic phosphoramidate prodrugs for HCV infection
US9192621B2 (en) 2012-09-27 2015-11-24 Idenix Pharmaceuticals Llc Esters and malonates of SATE prodrugs
US10513534B2 (en) 2012-10-08 2019-12-24 Idenix Pharmaceuticals Llc 2′-chloro nucleoside analogs for HCV infection
US9211300B2 (en) 2012-12-19 2015-12-15 Idenix Pharmaceuticals Llc 4′-fluoro nucleosides for the treatment of HCV
US9309275B2 (en) 2013-03-04 2016-04-12 Idenix Pharmaceuticals Llc 3′-deoxy nucleosides for the treatment of HCV
US10231986B2 (en) 2013-03-13 2019-03-19 Idenix Pharmaceuticals Llc Amino acid phosphoramidate pronucleotides of 2′-cyano, azido and amino nucleosides for the treatment of HCV
US9187515B2 (en) 2013-04-01 2015-11-17 Idenix Pharmaceuticals Llc 2′,4′-fluoro nucleosides for the treatment of HCV
US10005779B2 (en) 2013-06-05 2018-06-26 Idenix Pharmaceuticals Llc 1′,4′-thio nucleosides for the treatment of HCV
US10238680B2 (en) 2013-08-01 2019-03-26 Idenix Pharmaceuticals Llc D-amino acid phosphoramidate pronucleotides of halogeno pyrimidine compounds for liver disease
US10202411B2 (en) 2014-04-16 2019-02-12 Idenix Pharmaceuticals Llc 3′-substituted methyl or alkynyl nucleosides nucleotides for the treatment of HCV

Also Published As

Publication number Publication date
WO1993017651A2 (fr) 1993-09-16
DE4207363A1 (de) 1993-09-09

Similar Documents

Publication Publication Date Title
WO1993017651A3 (fr) Analogues nucleosidiques antiviraux, leur fabrication et leur utilisation
CA2068943A1 (fr) 1,3-oxathiolane utile dans le traitement de l'hepatite
AU6924796A (en) 1,3-oxathiolane nucleoside analogues in the treatment of hepatitis c
FI906212A0 (fi) Inhibitorer foer hiv-proteas, vilka aer anvaendbara vid av aids.
AU2001248331A1 (en) Medicaments against viral diseases
GB9116601D0 (en) 1,3-oxathiolane nucleoside analogues
FI893962L (fi) Vid vaord av aids anvaendbara hiv-proteas -inhibitorer.
FI891716A0 (fi) Hiv-proteasinhibitorer, som aer anvaendbara vid behandling av aids.
ATE199906T1 (de) Phosphonat-nukleotid ester-derivate
EP1164133A3 (fr) Nucléosides de béta-D-Dioxolane énantiomériquement Purs
AU7855191A (en) 2',3'-dideoxy-4'-thioribonucleosides as antiviral agents
CA2143204A1 (fr) Utilisation des analogues des didesoxynucleosides dans le traitement des infections virales
FI935780A0 (fi) HIV-proteasinhibitorer, vilka aer anvaendbara vid behandling av AIDS
DE69000743D1 (de) Antivirale tetrahydroimidazo(1,4)benzodiazepin-2-thione.
FI893948A0 (fi) Antiviral behandlingsfoerfarande.
CA2120743A1 (fr) Derives acycliques purine et pyrimidine de type alkenyl et alkynyl avec un substitut phosphonomethoxyalkyl et ayant une activite antivirale
HUP0100087A3 (en) Nucleosides analogues, the use thereof for producing medicaments useful against retroviral infections and hepatitis b virus and the same medicaments
DE68918215D1 (de) 2'-Halomethyliden, 2'-Ethenyliden und 2'-Ethynyl-Adenosinderivate.
EP0317128A3 (fr) Pyrimidine Nucléosides Anti-HIV
AU642751B2 (en) New embodiments of the HIV principal neutralizing determinant
AU3170193A (en) Therapeutic nucleosides
FI890116L (fi) Icke-reverterande rna-virus.
AU9179891A (en) Hiv reverse transcriptase vaccine
AU8334691A (en) Antiviral agent
CA2285463A1 (fr) Therapie combinee des infections au vih

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE

AK Designated states

Kind code of ref document: A3

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
122 Ep: pct application non-entry in european phase